Based on decades of experience in applying stirred-bed reactors for making peptides, we investigated whether thesecould be used for the manufacturing of oligonucleotides aswell. Join our webinar on scalable oligonucleotidemanufacturing with stirred-bed technology (SBT) to learn howwe can reach commercial oligonucleotides API production inmetric ton range with unbeaten process mass intensity. You willget insights into case studies, our SBT capacities for R&D tolarge scale production projects, and typical CMC activities forscale-up. Finally, we will share the distinct advantagesstirred-bed solid-phase oligonucleotide synthesis (SPOS) hasover classical fixed-bed SPOS.

Speakers:

Daniel Samson, PH.D. - Vice President, Head Oligonucleotides

Daniel brings 15 years of industry experience to the team, with an emphasis on TIDES process R&D, manufacturing and CMC development. He leads Bachems oligonucleotide unit including innovation projects, R&D and manufacturing activities. Daniel holds a PhD in organic chemistry from the University of Konstanz, and an MBA from the International Institute for Management Development (IMD), Lausanne. In previous stages of his career he was a lab head for process optimization, technology transfer, Quality by Design, and scale-up of synthetic peptide manufacturing procedures. From 2012, Daniel was a Vice President API Manufacturing and had full responsibility for all large-scale solid phase peptide and oligonucleotide syntheses, downstream operations, and CMC activities within Bachem AG.

Chris Mcgee, PH.D. - Vice President, Head Global Business Development

Chris leads the Global Business Development department at Bachem. Previously, he was Senior Director of Business Development (BD) for Bachem Americas. As Senior Director of BD, he was at the forefront of communications related to the development and manufacturing of new peptide and oligonucleotide-based chemical entities with his team of peptide experts in the field. Chris has nearly a decade of experience at Bachem and previously earned a Ph.D. in organic chemistry from the University of California, Irvine.

Click here to register >>>

Read more from the original source:

[WEBINAR] Scalable Oligonucleotide Manufacture With Stirred-Bed ... - Contract Pharma